Cellectar Biosciences, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold CLRB, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
6
Funds holding
$66000
Total value held
Buying
3 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Northern Trust Corp | $41252 | 14839 | +14839 | NEW BUY |
| 2 | Blackrock, Inc. | $13163 | 4735 | -10 | -0.21% |
| 3 | Ubs Group Ag | $8599 | 3093 | +3093 | NEW BUY |
| 4 | Barclays Plc | $1560 | 561 | +561 | NEW BUY |
| 5 | Morgan Stanley | $1418 | 510 | — | Held |
| 6 | Us Bancorp \De\ | $8 | 3 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.